Otrexup (Antares Pharma, Inc.)
Welcome to the PulseAid listing for the Otrexup drug offered from Antares Pharma, Inc.. This Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Antares Pharma, Inc. |
| NON-PROPRIETARY NAME: | methotrexate |
| SUBSTANCE NAME: | METHOTREXATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-10-11 |
| END MARKETING DATE: | 0000-00-00 |
Otrexup HUMAN PRESCRIPTION DRUG Details:
| Item Description | Otrexup from Antares Pharma, Inc. |
| LABELER NAME: | Antares Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/.4mL) |
| START MARKETING DATE: | 2013-10-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 54436-010_a05b9305-ebcc-419d-88c8-bb555c838c00 |
| PRODUCT NDC: | 54436-010 |
| APPLICATION NUMBER: | NDA204824 |
Other METHOTREXATE Pharmaceutical Manufacturers / Labelers:
